Abstract Two new quinone type compounds, variecolorquinones A (1) and B (2) together with eleven known related compounds 3ϳ13 have been isolated from the metabolites produced by the halotolerant fungal strain Aspergillus variecolor B-17. The structures of 1 and 2 were determined by spectroscopic methods. 1 exhibited selective cytotoxicity against A-549 cells with the IC 50 values of 3.0 mM. 2 showed cytotoxicity against HL60 and P388 cells with the IC 50 values of 1.3 and 3.7 m M, respectively.
Introduction
It demonstrated that halotolerant marine fungal species have evolved unique metabolic mechanisms that are responsive to salt concentrations and marine-derived fungal metabolite production could have implications for drug discovery [1] . Besides marine samples, halotolerant fungal species had been isolated from other hypersaline environment such as salterns, salines and dried fish. But, to the best of our knowledge, there were only a few reports on secondary metabolites of halotolerant fungus in the literature [2ϳ4] . In order to screen "talented strains" [5] to find structural novel and bioactive secondary metabolites, we continue to isolate and identify halotolerant microbes from both marine [6ϳ13] and other salt environments. As a result, a halotolerant fungal strain, Aspergillus variecolor B-17, was isolated from the sediments collected in Jilantai salt field, Alashan, Inner Mongolia, China.
The crude extract of the mycelia of A. variecolor B-17 showed significant cytotoxicity against the mouse cdc2 mutant cell line (tsFT210) and was subjected to flash column chromatography over silica gel, RP-18 and HPLC separation to afford two new quinone type compounds variecolorquinones A (1) and B (2), together with eleven known compounds, (2S)-2,3-dihydroxypropyl 1,6,8-trihydroxy-3-methyl-9,10-dioxoanthracene-2-carboxylate (3) [14] , emodin (4) [15] , physcion (5) [15] , questin (6) [15] , questinol (7) [15] , catenarin (8) [15] , erythroglaucin (9) [16] , rubrocristin (10) [16] , fallacinol (11) [15] , eurotinone (12) [17] and 2-methyleurotinone (13) [17] (Fig. 1) , by a bioassay-guided isolation procedure.
Materials and Methods

Strain
The working strain Aspergillus variecolor B-17 was isolated from the sediments collected in Jilantai salt field, Alashan, Inner Mongolia, China. It was identified by Prof. Li Tian, the First Institute of Oceanography, SOA, Qingdao, China. Working strain was prepared on Potato Dextrose agar slants containing 10% NaCl and stored at 4°C.
Fermentation
The fungus was grown under static conditions at 30°C for 28 days in thirty 1000-ml conical flasks containing the liquid medium (300 ml/flask) composed of (g/liter): glucose
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Wenliang Wang, Tianjiao Zhu, Hongwen Tao, Zhenyu Lu, Yuchun Fang, Qianqun Gu, Weiming Zhu (10) , maltose (20) , mannitol (20) , malt extract (3.0), monosodium glutamate (10), NaCl (120), NH 4 Cl (10), MgSO 4 · 7H 2 O (5.0) and KCl (5.0) after adjusting its pH to 7.0.
Extraction and Isolation
The fermented whole broth (9.0 liters) was filtered through cheese cloth to separate into supernatant and mycelia. The mycelia was extracted three times with Me 2 CO. The Me 2 CO solution was concentrated under reduced pressure to afford crude extract (7.8 g), showing strong cytotoxicity against the mouse cdc2 mutant cell line (tsFT210, IC 50 68 m g/ml) and antioxidation against 1,1-diphenyl-2-pierylhydrazyl (DPPH, IC 50 98 m g/ml). The crude extract was separated into 4 fractions on a silica gel column using a step gradient elution of CHCl 3 -MeOH. The fraction 1 (1.9 g) was separated into 5 subfractions on a silica gel column using a step gradient elution of petroleum ether : Me 2 CO. Subfraction 1-4 (73 mg) was crystallized from CHCl 3 /MeOH (v/v 9 : 1) to yield 5 (39 mg). 9 (11 mg) was isolated from the mother liquid of subfraction 1-4 by Sephadex LH-20 column (v/v 2 : 1 CHCl 3 /MeOH). The fraction 3 (0.8 g) was subjected to column chromatography over silica gel (v/v 93 : 7 CHCl 3 /MeOH) to afford 16 subfrations. Subfraction 3-2 (72 mg) was crystallized from CHCl 3 /MeOH (v/v 1 : 1) to yield 8 (59 mg). The mother liquid of subfraction 3-2, togather with the Fr. 3-3 and 3-4 were combined and subjected to HPLC separation (gradient elution of 70ϳ100% MeOH) to yield 4 (5.0 mg), 6 (7.0 mg), 7 (9.0 mg), 10 (7.0 mg) and 11 (6.0 mg). The Fr. 3-7 (59 mg) was further separated by HPLC to yield 2 (31 mg). Subfractions 3-14 (29 mg) and 3-15 (83 mg) were further separated by HPLC to yield 1 (15 mg) and 3 (45 mg), respectively. Subfractions 3-5 and 3-6 were combined and subjected to HPLC to yield 12 (31 mg) and 13 (23 mg).
Physico-chemical Analyses
Optical rotations were obtained on a JASCO P-1020 digital polarimeter. UV spectra were recorded on Beckmen DU ® 640 spectrophotometer. IR spectra were taken on a NICOLET NEXUS 470 spectrophotometer in KBr discs. 1 H-, 13 C-NMR and DEPT spectra and 2D-NMR were recorded on a JEOL JNM-ECP 600 spectrometer using TMS as internal standard and chemical shifts were recorded as d values. ESI-MS was measured on a Q-TOF ULTIMA GLOBAL GAA076 LC mass spectrometer. Semipreparative HPLC was performed on a SHIMADZU LC-6AD Liquid Chromatograph with SPD-M10A vp Diode Array Detector.
Biological Assay
Cell lines were grown in RPMI-1640 supplemented with 10% FBS under a humidified atmosphere of 5.0% CO 2 and 95% air at 37°C. Two hundred microliters of those cell suspensions at a density of 5ϫ10 4 cell/ml was plated in 96 well microtiter plates and incubated for 24 hours at the above conditions. Then 2.0 m l of the test compound solutions (in MeOH) at different concentrations was added to each well and further incubated for 72 hours in the same conditions. Twenty microliters of the MTT solution (5.0 mg/ml in RPMI-1640 medium) was added to each well and incubated for 4 hours. An old medium (150 m l) containing MTT was then gently replaced by DMSO and pipetted to dissolve any formazan crystals formed. Absorbance was then determined on a SPECTRA MAX PLUS plate reader at 540 nm.
In SRB assay, 200 ml of the cell suspensions were plated in 96-cell plates at a density of 2ϫ10 5 cell/ml. Then 2.0 ml of the test compound solutions (in MeOH) at different concentrations was added to each well and the culture was further incubated for 24 hours. Following drug exposure, the cells were fixed with 12% TCA and the cell layer was stained with 0.4% SRB. The absorbance of SRB solution was measured at 515 nm. Dose response curves were generated and the IC 50 values, the concentration of compound required to inhibit cell proliferation by 50%, were calculated from the linear portion of log dose response curves.
In DPPH scavenging assay, 160 ml of reaction mixtures containing test samples and 40 m M DPPH (Sigma) dissolved in methanol were plated in 96-cell plates and kept in dark for 30 minutes. After the reaction, absorbance was then measured at 517 nm, and percent inhibition was Table 2 .
Structure Determination 1 was obtained as a yellow amorphous powder. Its molecular formula was determined as C 20 H 18 O 9 based on HRESI-MS at m/z 401.0871 [MϪH] Ϫ (calcd 401.0873).
The diagnostic IR peaks were observed for hydroxyl and carbonyl at 3425 and 1718 cm Ϫ1 , respectively. The UV spectra absorptions at l max (log e) 223 (4.1), 251 (3.8), and 286 (3.9), 440 (3.5) suggested the presence of emodin skeleton in 1 [15] . Analysis of the 1D NMR spectra of 1 displayed three carbonyls, nine sp 2 quarternary carbons, three sp 2 methines, one oxygenated methine, two oxygenated methylenes, one methoxyl and one methyl (Table 1) [14] . Thus, the structure of 1 was elucidated as (2S)-2,3-dihydroxypropyl-1,6-dihydroxy-8-methoxy-3-methyl-9,10-dioxoanthracene-2-carboxylate.
2 was obtained as yellow amorphous powder. Its molecular formula was determined as C 17 (Table 1 ). According to 2D NMR spectrum, these protons and carbons were linked into two structural moieties, i.e. methyl 2-substituted-4-methyl-6-hydroxybenzoate and 2-substituted-6-methoxybenzoquinone. These two moieties were further connected together via a methylene which was confirmed by HMBC correlations between H-7 and C-1, C-2, C-3, C-8, C-9 and C-13, and between H-13 and C-7. These data are sufficient to assign the structure of 2 as methyl 2-hydroxy-6-[(5-methoxy-3,6-dioxocyclohexa-1,4-dienyl)methyl]-4-methylbenzoate (Fig. 2) .
Cytotoxity and Radical Scavenging Activity
The cytotoxicities of new compounds 1 and 2 were assayed in vitro against the P388 and HL-60 cell lines by the MTT method [18] , and BEL-7402 and A-549 cell lines by the SRB method [19] . The IC 50 values of 1 and 2 against P388, HL-60, BEL-7402 and A-549 cells were 266, 309, 114, 3.0 and 3.7, 1.3, 29 and 56 m M, respectively. 1 selectively inhibited the proliferation of A-549 cell and 2 inhibited the proliferation of P388 and HL-60 cells. 1, 2, 12 and 13 were also evaluated for their radical scavenging activity against DPPH [20] . 1 showed moderate activity with IC 50 values of 28 mM, while 2 was inactive (IC 50 Ͼ100 mM). 12 and 13 which were strong KDR kinase inhibitors [17] exhibited strong antioxidative activity against DPPH with IC 50 values of 6.0 m M and 11 m M, respectively (ascorbic acid as positive control, IC 50 22 mM).
